It was observed that the developed polymeric nanoparticles increased the early-stage CD8+ T cell immune surveillance against TNBC while reversing the inhibition profile of the late-stage CD8+ T cells in TNBC cells to prevent the tumor immune escape. The gene discussed is CD8A; the disease is neoplasm.